RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions